Preoperative Clinical Factors Associated with High-Risk Thyroid Cytology (Bethesda V-VI): A Retrospective Study of a Thyroidectomy Cohort
PDF

Özgün Araştırma

Preoperative Clinical Factors Associated with High-Risk Thyroid Cytology (Bethesda V-VI): A Retrospective Study of a Thyroidectomy Cohort

Forbes J Med 2026;7(1):107-114 DOI: 10.4274/forbes.galenos.2026.69345
,
PDF
İzin

Kaynakça

1

Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008;22:901-11.

2

Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614-7.

3

Li M, Dal Maso L, Pizzato M, Vaccarella S. Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 2024;12:824-36.

4

Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and management of thyroid nodules: a review. JAMA. 2018;319:914-24. Erratum in: JAMA. 2018;319:1622.

5

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.

6

Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2023;33:1039-44.

7

Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012;56:333-9.

8

Durante C, Hegedüs L, Czarniecka A, et al. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J. 2023;12:e230067.

9

Angelopoulos N, Androulakis I, Askitis DP, et al. Integrating clinical parameters into thyroid nodule malignancy risk: a retrospective evaluation based on ACR TI-RADS. J Clin Med. 2025;14:5352.

10

Cochran WG. “Some methods for strengthening the common chi-square test,”. Biometrics. 1954;10:417-51.

11

Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375-86.

12

Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27-38.

13

Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21:2409-19.

14

Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774-81.

15

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45.

16

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573-7.

17

Kyrilli A, Tacelli N, Russo L, et al. Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results. Eur Thyroid J. 2023;12:e230135.

18

Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343-1421. Erratum in: Thyroid. 2017;27:1462. Erratum in: Thyroid. 2025;35:1097.

19

Lau LW, Ghaznavi S, Frolkis AD, et al. Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis. Thyroid Res. 2021;14:3.

20

Lee JY, Yoo RE, Rhim Jh, et al. Validation of ultrasound risk stratification systems for cervical lymph node metastasis in patients with thyroid cancer. Cancers (Basel). 2022;14:2106.

21

Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121:487-91.

22

Kamran SC, Marqusee E, Kim MI, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013;98:564-70.

23

Cotter A, Jinih M. Thyroid nodule size and risk of malignancy: a systematic review. Discov Oncol. 2025;16:1188.

24

Alqahtani SM, Albalawi HI, Alalawi YS, AlFattani AA, Al-Sobhi SS. The impact of nodule size on malignancy risk in indeterminate thyroid nodules. Gland Surg. 2024;13:470-9.

25

Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24:27-34.

26

Kwong N, Medici M, Angell TE, et al. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J Clin Endocrinol Metab. 2015;100:4434-40.

27

Nilubol N, Zhang L, Kebebew E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid. 2013;23:695-702.

28

Brandler TC, Aziz MS, Coutsouvelis C, et al. Young investigator challenge: atypia of undetermined significance in thyroid FNA: Standardized terminology without standardized management--a closer look at repeat FNA and quality measures. Cancer Cytopathol. 2016;124:37-43.

29

VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? Am J Clin Pathol. 2011;135:770-5.

30

Durante C, Costante G, Lucisano G, et al. The natural history of benign thyroid nodules. JAMA. 2015;313:926-35.

31

Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14:587-95.

32

Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017;6:225-37.

33

Patel KN, Angell TE, Babiarz J, et al. Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules. JAMA Surg. 2018;153:817-24.

34

Steward DL, Carty SE, Sippel RS, et al. Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study. JAMA Oncol. 2019;5:204-12. Erratum in: JAMA Oncol. 2019;5:271.